Advances in the treatment of neuromyelitis optic spectrum disorder
Neuromyelitis optic spectrum disorder (NMOSD) is a rare autoimmune disease characterized by recurrent episodes and severe debilitation.It primarily involves the central nervous system and is associated with the presence of aquaporin-4 antibodies.Effective management of NMOSD necessitates long-term therapeutic Adjustment Pin strategies that focus on